Modifying the risk: Once-a-day bathing "at risk" patients in the intensive care unit with chlorhexidine gluconate

Publication Date

2014

Journal Title

Am J Infect Control

Abstract

Chlorhexidine gluconate (CHG) decreases hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) that can cause colonization and infection. A standard approach is the bathing of all patients with CHG to prevent MRSA transmission. To decrease CHG utilization, this study assessed selective daily administration of CHG bathing to intensive care unit patients who had an MRSA-positive result or a central venous catheter. This risk-based approach was associated with a 72% decrease in hospital-acquired MRSA transmission rate. Copyright (C) 2014 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Volume Number

42

Issue Number

5

Pages

571-573

Document Type

Article

EPub Date

2014/04/30

Status

Faculty, Northwell Researcher

Facility

School of Medicine; Northwell Health

Primary Department

Emergency Medicine

Additional Departments

Infectious Disease

PMID

24773800

DOI

10.1016/j.ajic.2013.12.026

Full Text for Zucker SOM at Hofstra/Northwell
For the public and Northwell Health campuses

Share

COinS